Anxiety Management Devices Market
PUBLISHED: 2026 ID: SMRC35277
SHARE
SHARE

Anxiety Management Devices Market

Anxiety Management Devices Market Forecasts to 2034 - Global Analysis By Product (Wearable Devices, Neurostimulation Devices, Biofeedback & Neurofeedback Devices, Virtual Reality (VR) Devices, Audiovisual Relaxation Devices, Mobile Connected Devices), Treatment Modality, Distribution Channel, Technology, Application, End User and By Geography

4.6 (24 reviews)
4.6 (24 reviews)
Published: 2026 ID: SMRC35277

Due to ongoing shifts in global trade and tariffs, the market outlook will be refreshed before delivery, including updated forecasts and quantified impact analysis. Recommendations and Conclusions will also be revised to offer strategic guidance for navigating the evolving international landscape.
Loading...

According to Stratistics MRC, the Global Anxiety Management Devices Market is accounted for $3.09 billion in 2026 and is expected to reach $5.63 billion by 2034 growing at a CAGR of 7.7% during the forecast period. Anxiety management devices are specialized medical or wellness technologies designed to monitor, alleviate, and regulate symptoms associated with Anxiety Disorders. These devices utilize approaches such as neurostimulation, biofeedback, heart rate variability tracking, and guided relaxation to influence physiological and psychological responses to stress. Common formats include wearable devices, handheld stimulators, and mobile-connected systems that provide real-time feedback and personalized interventions. Widely used in clinical and home settings, they offer non-invasive, drug-free alternatives or complements to traditional therapies, improving patient outcomes, adherence, and overall mental well-being.
 
Market Dynamics:

Driver:

Rising prevalence of Anxiety Disorders


The increasing global burden of Anxiety Disorders is a primary driver of the anxiety management devices market. Factors such as urbanization, high work pressure, social isolation, and digital fatigue are contributing to a surge in anxiety-related conditions. This growing patient pool is driving demand for accessible, non-invasive, and continuous treatment solutions. Additionally, early diagnosis trends and rising mental health awareness are encouraging individuals to adopt device-based therapies, thereby accelerating market growth across both clinical and homecare environments.

Restraint:

High cost of advanced devices


The high cost associated with technologically advanced anxiety management devices remains a significant barrier to widespread adoption. Devices incorporating neurostimulation, AI-based analytics, and real-time monitoring systems often involve substantial manufacturing and development expenses, making them less affordable, particularly in emerging economies. Limited insurance reimbursement policies further exacerbate the financial burden on patients. As a result, cost sensitivity restricts market penetration, especially among lower-income populations, thereby slowing the overall growth.

Opportunity:

Technological advancements


Rapid technological advancements present substantial growth opportunities in the market. Innovations in wearable technology, artificial intelligence, and biofeedback systems are enhancing device accuracy, usability, and personalization. Integration with mobile applications and cloud-based platforms enables real-time monitoring and data-driven insights, improving treatment outcomes. Furthermore, the development of compact and cost-effective devices is expanding accessibility. These advancements are fostering increased adoption among consumers, positioning technology as a key enabler of future market expansion.

Threat:

Low awareness in developing regions


Low awareness regarding mental health conditions and available treatment technologies poses a significant threat to market growth in developing regions. In many areas, mental health issues remain stigmatized, leading to underdiagnosis and limited treatment-seeking behavior. Additionally, lack of education about anxiety management devices and their benefits restricts adoption. Insufficient healthcare infrastructure and limited access to trained professionals further compound the challenge. These factors collectively hinder market penetration and slow the adoption.

Covid-19 Impact:

The COVID-19 pandemic had a profound impact on the market, significantly increasing the prevalence of stress, anxiety, and related mental health disorders. Social isolation, economic uncertainty, and health concerns led to a surge in demand for remote and non-invasive treatment solutions. This accelerated the adoption of wearable and home-based anxiety management devices. Additionally, the expansion of telehealth services during the pandemic supported device integration and monitoring. However, supply chain disruptions and economic constraints temporarily affected production and accessibility.

The hospitals segment is expected to be the largest during the forecast period

The hospitals segment is expected to account for the largest market share during the forecast period, due to availability of advanced healthcare infrastructure and skilled professionals. Hospitals serve as primary centers for diagnosis, treatment, and monitoring of anxiety-related conditions, ensuring higher adoption of clinically validated devices. The integration of anxiety management technologies with other therapeutic interventions enhances patient outcomes. Moreover, increased patient inflow, access to reimbursement frameworks, and the presence of multidisciplinary care teams further strengthen the dominance of hospitals in the market.

The neurofeedback segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the neurofeedback segment is predicted to witness the highest growth rate, due to effectiveness in training brain activity and improving emotional regulation. This non-invasive technique provides real time feedback on brainwave patterns, enabling patients to self-regulate anxiety responses. Growing preference for personalized and drug-free therapies is boosting its adoption. Additionally, technological improvements and increasing clinical validation are enhancing its credibility among healthcare providers. The rising demand for cognitive performance enhancement further supports the rapid growth of this segment.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high awareness of mental health issues, and strong adoption of innovative technologies. The region benefits from significant investments in research and development, along with the presence of key market players. Favorable reimbursement policies and widespread availability of anxiety management devices further drive market growth. Additionally, the rising prevalence of anxiety disorders and increasing acceptance of non-invasive treatments contribute to regional dominance.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to increasing awareness of mental health and rising disposable incomes. Rapid urbanization and changing lifestyles are contributing to higher stress and anxiety levels, driving demand for effective management solutions. Government initiatives promoting mental health and digital healthcare adoption further support market expansion. Additionally, the growing penetration of wearable technologies and mobile health platforms is accelerating the adoption of anxiety management devices across the region.

Key players in the market

Some of the key players in Anxiety Management Devices Market include Fisher Wallace Laboratories, Electromedical Products International, Mind Alive Inc., BrainMaster Technologies Inc., Thought Technology Ltd., Mind Media B.V., Neurobit Systems, HeartMath LLC, NeuroSky Inc., InteraXon Inc., Emotiv Inc., Neuroelectrics, BrainsWay Ltd., Neuronetics Inc. and Medtronic plc.

Key Developments:

In March 2026, Medtronic plc expanded its multiyear alliance with GE HealthCare to accelerate next-generation innovation, integrate advanced patient monitoring technologies, and enhance clinical solutions, enabling more efficient workflows, improved patient outcomes, and broader access to connected, data-driven healthcare systems globally.

In February 2026, Medtronic announced its intent to acquire CathWorks for up to $585 million, strengthening its cardiovascular portfolio. The deal builds on their 2022 partnership and integrates AI-based FFRangio technology to enhance coronary disease diagnosis and treatment, pending regulatory approval.

Products Covered:
• Wearable Devices
• Neurostimulation Devices
• Biofeedback & Neurofeedback Devices
• Virtual Reality (VR) Devices
• Audiovisual Relaxation Devices
• Mobile Connected Devices

Treatment Modalities Covered:
• Cognitive Behavioral Therapy (CBT) Devices
• Meditation & Relaxation Devices
• Biofeedback Therapy Devices
• Neurostimulation Therapy Devices

Distribution Channels Covered:
• Online Sales
• Offline Sales

Technologies Covered:
• Biofeedback
• Neurofeedback
• Electrotherapy
• VR-Based Therapy
• Sensor-Based Monitoring

Applications Covered:
• Generalized Anxiety Disorder
• Panic Disorder
• Social Anxiety Disorder
• Post-Traumatic Stress Disorder (PTSD)
• Obsessive Compulsive Disorder (OCD)
• Specific Phobias
• Other Applications

End Users Covered:
• Hospitals
• Specialty Clinics
• Home Care Settings
• Rehabilitation Centers
• Educational Institutions

Regions Covered:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
o Netherlands
o Belgium
o Sweden
o Switzerland
o Poland
o Rest of Europe
• Asia Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Thailand
o Malaysia
o Singapore
o Vietnam
o Rest of Asia Pacific   
• South America
o Brazil
o Argentina
o Colombia
o Chile
o Peru
o Rest of South America
• Rest of the World (RoW)
o Middle East
§ Saudi Arabia
§ United Arab Emirates
§ Qatar
§ Israel
§ Rest of Middle East
o Africa
§ South Africa
§ Egypt
§ Morocco
§ Rest of Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary    
 1.1 Market Snapshot and Key Highlights 
 1.2 Growth Drivers, Challenges, and Opportunities
 1.3 Competitive Landscape Overview 
 1.4 Strategic Insights and Recommendations 
      
2 Research Framework   
 2.1 Study Objectives and Scope  
 2.2 Stakeholder Analysis  
 2.3 Research Assumptions and Limitations 
 2.4 Research Methodology  
  2.4.1 Data Collection (Primary and Secondary)
  2.4.2 Data Modeling and Estimation Techniques
  2.4.3 Data Validation and Triangulation
  2.4.4 Analytical and Forecasting Approach
      
3 Market Dynamics and Trend Analysis  
 3.1 Market Definition and Structure 
 3.2 Key Market Drivers   
 3.3 Market Restraints and Challenges 
 3.4 Growth Opportunities and Investment Hotspots
 3.5 Industry Threats and Risk Assessment 
 3.6 Technology and Innovation Landscape 
 3.7 Emerging and High-Growth Markets 
 3.8 Regulatory and Policy Environment 
 3.9 Impact of COVID-19 and Recovery Outlook
      
4 Competitive and Strategic Assessment  
 4.1 Porter's Five Forces Analysis  
  4.1.1 Supplier Bargaining Power 
  4.1.2 Buyer Bargaining Power 
  4.1.3 Threat of Substitutes 
  4.1.4 Threat of New Entrants 
  4.1.5 Competitive Rivalry  
 4.2 Market Share Analysis of Key Players 
 4.3 Product Benchmarking and Performance Comparison
      
5 Global Anxiety Management Devices Market, By Product
 5.1 Wearable Devices   
 5.2 Neurostimulation Devices  
 5.3 Biofeedback & Neurofeedback Devices 
 5.4 Virtual Reality (VR) Devices  
 5.5 Audiovisual Relaxation Devices 
 5.6 Mobile Connected Devices  
      
6 Global Anxiety Management Devices Market, By Treatment Modality
 6.1 Cognitive Behavioral Therapy (CBT) Devices
 6.2 Meditation & Relaxation Devices 
 6.3 Biofeedback Therapy Devices  
 6.4 Neurostimulation Therapy Devices 
      
7 Global Anxiety Management Devices Market, By Distribution Channel
 7.1 Online Sales   
 7.2 Offline Sales   
      
8 Global Anxiety Management Devices Market, By Technology
 8.1 Biofeedback   
 8.2 Neurofeedback   
 8.3 Electrotherapy   
 8.4 VR-Based Therapy   
 8.5 Sensor-Based Monitoring  
      
9 Global Anxiety Management Devices Market, By Application
 9.1 Generalized Anxiety Disorder  
 9.2 Panic Disorder   
 9.3 Social Anxiety Disorder  
 9.4 Post-Traumatic Stress Disorder (PTSD) 
 9.5 Obsessive Compulsive Disorder (OCD) 
 9.6 Specific Phobias   
 9.7 Other Applications   
      
10 Global Anxiety Management Devices Market, By End User
 10.1 Hospitals    
 10.2 Specialty Clinics   
 10.3 Home Care Settings   
 10.4 Rehabilitation Centers  
 10.5 Educational Institutions  
      
11 Global Anxiety Management Devices Market, By Geography

 11.1 North America   
  11.1.1 United States  
  11.1.2 Canada   
  11.1.3 Mexico   
 11.2 Europe    
  11.2.1 United Kingdom  
  11.2.2 Germany   
  11.2.3 France   
  11.2.4 Italy   
  11.2.5 Spain   
  11.2.6 Netherlands  
  11.2.7 Belgium   
  11.2.8 Sweden   
  11.2.9 Switzerland  
  11.2.10 Poland   
  11.2.11 Rest of Europe  
 11.3 Asia Pacific   
  11.3.1 China   
  11.3.2 Japan   
  11.3.3 India   
  11.3.4 South Korea  
  11.3.5 Australia   
  11.3.6 Indonesia  
  11.3.7 Thailand   
  11.3.8 Malaysia   
  11.3.9 Singapore  
  11.3.10 Vietnam   
  11.3.11 Rest of Asia Pacific  
 11.4 South America   
  11.4.1 Brazil   
  11.4.2 Argentina  
  11.4.3 Colombia   
  11.4.4 Chile   
  11.4.5 Peru   
  11.4.6 Rest of South America 
 11.5 Rest of the World (RoW)  
  11.5.1 Middle East  
   11.5.1.1 Saudi Arabia 
   11.5.1.2 United Arab Emirates
   11.5.1.3 Qatar  
   11.5.1.4 Israel  
   11.5.1.5 Rest of Middle East 
  11.5.2 Africa   
   11.5.2.1 South Africa 
   11.5.2.2 Egypt  
   11.5.2.3 Morocco  
   11.5.2.4 Rest of Africa 
      
12 Strategic Market Intelligence   
 12.1 Industry Value Network and Supply Chain Assessment
 12.2 White-Space and Opportunity Mapping 
 12.3 Product Evolution and Market Life Cycle Analysis
 12.4 Channel, Distributor, and Go-to-Market Assessment
      
13 Industry Developments and Strategic Initiatives 

 13.1 Mergers and Acquisitions  
 13.2 Partnerships, Alliances, and Joint Ventures
 13.3 New Product Launches and Certifications
 13.4 Capacity Expansion and Investments 
 13.5 Other Strategic Initiatives  
      
14 Company Profiles    
 14.1 Fisher Wallace Laboratories  
 14.2 Electromedical Products International 
 14.3 Mind Alive Inc.   
 14.4 BrainMaster Technologies Inc.  
 14.5 Thought Technology Ltd.  
 14.6 Mind Media B.V.   
 14.7 Neurobit Systems   
 14.8 HeartMath LLC   
 14.9 NeuroSky Inc.   
 14.10 InteraXon Inc.   
 14.11 Emotiv Inc.   
 14.12 Neuroelectrics   
 14.13 BrainsWay Ltd.   
 14.14 Neuronetics Inc.   
 14.15 Medtronic plc   
      
List of Tables     
1 Global Anxiety Management Devices Market Outlook, By Region (2023-2034) ($MN)
2 Global Anxiety Management Devices Market Outlook, By Product (2023-2034) ($MN)
3 Global Anxiety Management Devices Market Outlook, By Wearable Devices (2023-2034) ($MN)
4 Global Anxiety Management Devices Market Outlook, By Neurostimulation Devices (2023-2034) ($MN)
5 Global Anxiety Management Devices Market Outlook, By Biofeedback & Neurofeedback Devices (2023-2034) ($MN)
6 Global Anxiety Management Devices Market Outlook, By Virtual Reality (VR) Devices (2023-2034) ($MN)
7 Global Anxiety Management Devices Market Outlook, By Audiovisual Relaxation Devices (2023-2034) ($MN)
8 Global Anxiety Management Devices Market Outlook, By Mobile Connected Devices (2023-2034) ($MN)
9 Global Anxiety Management Devices Market Outlook, By Treatment Modality (2023-2034) ($MN)
10 Global Anxiety Management Devices Market Outlook, By Cognitive Behavioral Therapy (CBT) Devices (2023-2034) ($MN)
11 Global Anxiety Management Devices Market Outlook, By Meditation & Relaxation Devices (2023-2034) ($MN)
12 Global Anxiety Management Devices Market Outlook, By Biofeedback Therapy Devices (2023-2034) ($MN)
13 Global Anxiety Management Devices Market Outlook, By Neurostimulation Therapy Devices (2023-2034) ($MN)
14 Global Anxiety Management Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
15 Global Anxiety Management Devices Market Outlook, By Online Sales (2023-2034) ($MN)
16 Global Anxiety Management Devices Market Outlook, By Offline Sales (2023-2034) ($MN)
17 Global Anxiety Management Devices Market Outlook, By Technology (2023-2034) ($MN)
18 Global Anxiety Management Devices Market Outlook, By Biofeedback (2023-2034) ($MN)
19 Global Anxiety Management Devices Market Outlook, By Neurofeedback (2023-2034) ($MN)
20 Global Anxiety Management Devices Market Outlook, By Electrotherapy (2023-2034) ($MN)
21 Global Anxiety Management Devices Market Outlook, By VR-Based Therapy (2023-2034) ($MN)
22 Global Anxiety Management Devices Market Outlook, By Sensor-Based Monitoring (2023-2034) ($MN)
23 Global Anxiety Management Devices Market Outlook, By Application (2023-2034) ($MN)
24 Global Anxiety Management Devices Market Outlook, By Generalized Anxiety Disorder (2023-2034) ($MN)
25 Global Anxiety Management Devices Market Outlook, By Panic Disorder (2023-2034) ($MN)
26 Global Anxiety Management Devices Market Outlook, By Social Anxiety Disorder (2023-2034) ($MN)
27 Global Anxiety Management Devices Market Outlook, By Post-Traumatic Stress Disorder (PTSD) (2023-2034) ($MN)
28 Global Anxiety Management Devices Market Outlook, By Obsessive Compulsive Disorder (OCD) (2023-2034) ($MN)
29 Global Anxiety Management Devices Market Outlook, By Specific Phobias (2023-2034) ($MN)
30 Global Anxiety Management Devices Market Outlook, By Other Applications (2023-2034) ($MN)
31 Global Anxiety Management Devices Market Outlook, By End User (2023-2034) ($MN)
32 Global Anxiety Management Devices Market Outlook, By Hospitals (2023-2034) ($MN)
33 Global Anxiety Management Devices Market Outlook, By Specialty Clinics (2023-2034) ($MN)
34 Global Anxiety Management Devices Market Outlook, By Home Care Settings (2023-2034) ($MN)
35 Global Anxiety Management Devices Market Outlook, By Rehabilitation Centers (2023-2034) ($MN)
36 Global Anxiety Management Devices Market Outlook, By Educational Institutions (2023-2034) ($MN)
      
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We offer complimentary customization of up to 15% with every purchase.

To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .

Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials